Insulet Corporation (PODD)
Debt-to-assets ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | 1,368,600 | 1,368,800 | 1,374,300 | 1,379,800 | 1,385,200 | 1,390,500 | 1,248,800 | 1,257,000 | 1,235,200 | 1,051,600 | 1,043,700 | 921,500 | 910,200 | 899,000 | 887,900 | 985,771 | 607,351 | 599,601 |
Total assets | US$ in thousands | 2,588,200 | 2,467,700 | 2,385,800 | 2,289,100 | 2,251,100 | 2,166,200 | 2,113,700 | 2,069,200 | 2,048,800 | 1,998,900 | 1,923,700 | 1,840,100 | 1,872,900 | 1,710,600 | 1,626,700 | 1,108,200 | 1,142,900 | 1,268,390 | 977,723 | 952,612 |
Debt-to-assets ratio | 0.00 | 0.00 | 0.57 | 0.60 | 0.61 | 0.64 | 0.66 | 0.67 | 0.61 | 0.63 | 0.64 | 0.57 | 0.56 | 0.54 | 0.56 | 0.81 | 0.78 | 0.78 | 0.62 | 0.63 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $2,588,200K
= 0.00
The debt-to-assets ratio of Insulet Corporation has shown a decreasing trend over the past eight quarters, indicating a reduction in the company's reliance on debt to finance its operations and investments. The ratio decreased from 0.68 in Q1 2022 to 0.55 in Q4 2023. This signifies that the company's level of debt relative to its total assets has declined, which may suggest improved financial stability and reduced financial risk. Insulet Corporation's decreasing debt-to-assets ratio may indicate effective debt management and potentially stronger financial health.
Peer comparison
Dec 31, 2023
Company name
Symbol
Debt-to-assets ratio
Insulet Corporation
PODD
0.00
3M Company
MMM
0.26
Artivion Inc
AORT
0.39
Baxter International Inc
BAX
0.00
Becton Dickinson and Company
BDX
0.27
Boston Scientific Corp
BSX
0.00
DexCom Inc
DXCM
0.39
Embecta Corp
EMBC
1.31
Glaukos Corp
GKOS
0.30
Globus Medical
GMED
0.08
Haemonetics Corporation
HAE
0.36